Galectin Therapeutics
Galectin Therapeutics Inc.
4960 Peachtree Industrial Boulevard
Suite 240
Norcross, GA 30071
Phone: (678) 620-3186Website: https://galectintherapeutics.com/
Latest news
- Pro-Pharmaceuticals Submits Data to FDA for Davanat NDA to Treat Advanced Colorectal Cancer
15 September 2008 - Pro-Pharmaceuticals Announces Submission of Drug Master File forDavanat to FDA
20 May 2008 - Pro-Pharmaceuticals Updates NDA Filing for Davanat
1 May 2008 - Pro-Pharmaceuticals Selects SAFC, a Division of Sigma-Aldrich, toSubmit a Drug Master File
19 December 2007 - Pro-Pharmaceuticals Submits Data to Begin a 505 (b)(2) Filing withthe FDA for a New Formulation of Irinotecan to be Co-administeredwith Davanat as a Functional Excipient
11 June 2007 - Pro-Pharmaceuticals Receives Letter from the FDA for New DrugApplication for Davanat/ 5-FU
11 April 2007 - Pro-Pharmaceuticals' Begins Process of New Drug Application Submission with the FDA for Co-administration of Davanat with 5-FU in Cancer Patients
7 February 2007
